+987.9%
MRNA vs NYT
+16.5%
+971.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NYT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -0.9% | +14.0% | +13.5% |
| 7D | +20.6% | -3.9% | +24.5% | +22.5% |
| 30D | +27.1% | +4.3% | +22.9% | +24.3% |
| 3M | +353.4% | -11.7% | +365.1% | +359.9% |
| 6M | +446.3% | -14.4% | +460.7% | +450.9% |
| YTD | +776.2% | -3.0% | +779.2% | +752.3% |
| 1Y | +987.9% | +16.5% | +971.4% | +876.1% |
| All | +987.9% | +16.5% | +971.4% | +876.1% |
Cumulative growth
Daily Returns
Daily percentage return beside NYT.
Daily Out/Under-Performance
Portfolio return minus NYT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NYT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NYT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling